Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
National CineMedia
NCMI
$259M
| $9.97M | 0.01% |
136,709
+6,344
| +5% | +$478K |
|
1452
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
| $9.96M | 0.01% |
192,300
+15,686
| +9% | +$814K |
|
1453
Integra LifeSciences
IART
$1.43B
| $9.95M | 0.01% |
170,760
-102,300
| -37% | -$6.09M |
|
1454
Wells Fargo
WFC
$267B
| $9.94M | 0.01% |
184,758
-2,536,075
| -93% | -$133M |
|
1455
Boot Barn
BOOT
$4.93B
| $9.91M | 0.01% |
222,500
-171,400
| -44% | -$6.77M |
|
1456
Unifirst Corp
UNF
$5.2B
| $9.9M | 0.01% |
49,000
-29,000
| -37% | -$5.88M |
|
|
OPB
1457
DELISTED
Opus Bank Common Stock
OPB
| $9.89M | 0.01% |
382,210
+177,506
| +87% | +$4.39M |
|
1458
Applied Industrial Technologies
AIT
$13.3B
| $9.89M | 0.01% |
148,250
+11,700
| +9% | +$718K |
|
|
VSTO
1459
DELISTED
Vista Outdoor Inc.
VSTO
| $9.87M | 0.01% |
1,319,300
+42,600
| +3% | +$320K |
|
|
ILPT
1460
Industrial Logistics Properties Trust
ILPT
$595M
| $9.83M | 0.01% |
438,380
+166,000
| +61% | +$3.56M |
|
1461
Provident Financial
PROV
$112M
| $9.81M | 0.01% |
447,847
-4,275
| -0.9% | -$90.7K |
|
1462
Enterprise Products Partners
EPD
$83.2B
| $9.78M | 0.01% |
347,433
+34,242
| +11% | +$928K |
|
1463
Marchex
MCHX
$81.5M
| $9.78M | 0.01% |
2,587,172
+81,423
| +3% | +$293K |
|
1464
First Bancorp
FBP
$4.52B
| $9.76M | 0.01% |
921,634
-222,944
| -19% | -$2.33M |
|
|
TPCO
1465
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $9.73M | 0.01% |
739,700
+58,000
| +9% | +$610K |
|
1466
InterContinental Hotels
IHG
$23.5B
| $9.71M | 0.01% |
141,364
-1,300
| -0.9% | -$81K |
|
1467
Kilroy Realty
KRC
$4.26B
| $9.71M | 0.01% |
115,700
+35,300
| +44% | +$2.88M |
|
1468
Standard BioTools
LAB
$285M
| $9.7M | 0.01% |
2,788,100
+42,740
| +2% | +$150K |
|
1469
American Superconductor
AMSC
$1.54B
| $9.69M | 0.01% |
1,234,617
-14,541
| -1% | -$117K |
|
|
MIXT
1470
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $9.67M | 0.01% |
745,800
+24,600
| +3% | +$311K |
|
1471
Newmark Group
NMRK
$2.75B
| $9.67M | 0.01% |
+718,545
| New | +$8.38M |
|
1472
Vanguard Short-Term Bond ETF
BSV
$45.7B
| $9.66M | 0.01% |
+119,800
| New | +$9.67M |
|
1473
Teledyne Technologies
TDY
$31.4B
| $9.63M | 0.01% |
+27,800
| New | +$9.35M |
|
|
ACC
1474
DELISTED
American Campus Communities, Inc.
ACC
| $9.62M | 0.01% |
204,528
+55,200
| +37% | +$2.64M |
|
1475
Harrow
HROW
$1.54B
| $9.62M | 0.01% |
1,236,206
-16,500
| -1% | -$95.6K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.